Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: A cross-sectional correlational study

Jehan S Al-Rahimi, Nada M Nass, Shahira A Hassoubah, Dhuha Y Wazqar, Soha A Alamoudi, Jehan S Al-Rahimi, Nada M Nass, Shahira A Hassoubah, Dhuha Y Wazqar, Soha A Alamoudi

Abstract

Coronavirus disease 2019 (COVID-19) infection has become a clinical threat to healthy people as well as immunocompromised patients and those with pre-existing chronic diseases around the world. This study, which used a cross-sectional correlational design, aimed to assess the levels of fear and health anxiety and to investigate their predictors during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia. Sociodemographic and clinical data, fear of COVID-19, and health anxiety measurements were collected by online surveys from June 15 to July 15, 2020. Univariate and multiple linear regression analysis was used to identify predictors. A total of 1,030 patients in 13 provinces in Saudi Arabia completed the questionnaire. A significant number of patients with chronic diseases experienced considerable levels of fear and anxiety during the COVID-19 outbreak. It was found that 21.44% of participants met the criteria for anxiety cases, and 19.4% were considered borderline anxiety cases. In regression analysis, significant predictors of fear and health anxiety were female gender, lower education, middle-aged, divorced or widowed, receiving immunosuppressants, type of chronic disease (Crohn's disease, hypertension, and cardiovascular diseases), and media use as a source of knowledge about COVID-19. Immunocompromised and chronic disease patients are vulnerable to fear and anxiety during epidemic infectious diseases such as COVID-19. Optimizing this population's compliance with appropriate infection prevention and control strategies is crucial during the infectious outbreaks to ensure their safety, to decrease the risk of infection and serious complications, and reduce their fear and health anxiety. Effective positive psychological interventions and support strategies also need to be immediately implemented to increase psychological resilience and improve the mental health of these patients. Due to the COVID-19 outbreak, chronic disease patients in Saudi Arabia need special attention from health authorities, policymakers, and healthcare professionals to manage maladaptive forms of health anxiety and fear.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y et al.. Early transmission dynamics in Wuhan, China, of novel Coronavirus–infected pneumonia. N Engl J Med. 2020; 382(19): 1199–1207. 10.1056/NEJMoa2001316
    1. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report-147. Available from: https://www. . Accessed 19 January 2021. 2020.
    1. Abueish T. Saudi Arabia reports 4,233 new cases, highest daily rise so far. Al Arabiya. Available from: . Accessed 22 June 2020.2020.
    1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomedica. 2020; 91(1): 157–160. 10.23750/abm.v91i1.9397
    1. World Health Organization (WHO). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available from: . Accessed 2 June 2020. 2020.
    1. CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019-United States, February 12–March 28, 2020. Morb Mortal Wkly Rep. 2020; 69(13): 382–386. 10.15585/mmwr.mm6913e2.
    1. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T et al.. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7): 811–818. 10.1001/jamacardio.2020.1017
    1. Liang W, Guan W, Chen R, Wang W, Li J, Xu K et al.. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncol. 2020; 21: 335–337. 10.1016/S1470-2045(20)30096-6
    1. Memish ZA, Jaber S, Mokdad AH, AlMazroa MA, Murray CJ, Al Rabeeah AA. Burden of disease, injuries, and risk factors in the Kingdom of Saudi Arabia, 1990–2010. Prev Chronic Dis. 2014; 11 (E169): 140176. 10.5888/pcd11.140176.
    1. Saquib N, Saquib J, Alhadlag A, Albakour MA, Aljumah B, Sughayyir M et al.. Chronic disease prevalence among elderly Saudi men. Int. J. Health Sci. 2017; 11(5), 11–16. .
    1. The Institute for Health Metrics and Evaluation (IHME). Saudi Arabia. Available from: . Accessed 19 January 2021. 2020.
    1. Al Dawish MA, Robert AA, Braham R, Al Hayek AA, Al Saeed A, Ahmed RA et al.. Diabetes mellitus in Saudi Arabia: a review of the recent literature. Curr Diabetes Rev. 2016; 12(4): 359–368. 10.2174/1573399811666150724095130
    1. Jazieh AR, Da’ar OB, Alkaiyat M, Zaatreh YA, Saad AA, Bustami R et al.. Cancer incidence trends from 1999 to 2015 and contributions of various cancer types to the overall burden: projections to 2030 and extrapolation of economic burden in Saudi Arabia. Cancer Manag Res. 2019; 2019(11): 9665–9674. 10.2147/CMAR.S222667
    1. Chudasama YV, Gillies CL, Zaccardi F, Coles B, Davies MJ, Seidu S et al.. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020; 14(5): 965–967. 10.1016/j.dsx.2020.06.042
    1. Gorrochategi MP, Munitis ME, Santamaria MD, Etxebarria NO. Stress, anxiety, and depression in people aged over 60 in the COVID19 outbreak in a sample collected in northern Spain. Am J Geriatr Psychiatry. 2020. Available from: 10.1016/j.jagp.2020.05.022.
    1. Pellino G, Spinelli A. How COVID-19 outbreak is impacting colorectal cancer patients in Italy: a long shadow beyond infection. Dis Colon Rectum. 2020; 63(6): 720–722. 10.1097/DCR.0000000000001685
    1. Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. The International J Soc Psychiatry. 2020; 66(5): 504–511. 10.1177/0020764020927051
    1. Green SB. How many subjects does it take to do a regression analysis. Multivariate Behav Res. 1991; 26(3): 499–510. 10.1207/s15327906mbr2603_7
    1. Bujang MA, Sa’at N, Sidik TMA. Determination of minimum sample size requirement for multiple linear regression and analysis of covariance based on experimental and non-experimental studies. Epidemiol Biostat Public Health. 2017; 14(3): e12117-1–e12117-9. 10.2427/12117.
    1. Bullen PB. How to choose a sample size (for the statistically challenged). Available from: . Accessed 10 March 2021. 2014.
    1. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2020. Available from: 10.1007/s11469-020-00270-8
    1. Alyami M, Henning M, Krägeloh CU, Alyami H. Psychometric evaluation of the Arabic version of the fear of COVID-19 scale. Int J Ment Health Addict. 2020. Available from: 10.1007/s11469-020-00316-x
    1. Satici B, Gocet-Tekin E, Deniz ME, Satici SA. Adaptation of the fear of COVID-19 scale: its association with psychological distress and life satisfaction in Turkey. Int J Ment Health Addict. 2020. Available from: 10.1007/s11469-020-00294-0
    1. Soraci P, Ferrari A, Abbiati FA, Del Fante E, De Pace R, Urso A et al.. Validation and psychometric evaluation of the Italian version of the Fear of COVID-19 Scale. Int J Ment Health Addict. 2020. Available from: 10.1007/s11469-020-00277-1
    1. Sakib N, Bhuiyan AKMI, Hossain S, Al Mamun F, Hosen I, Abdullah AH et al.. Psychometric validation of the Bangla Fear of COVID-19 Scale: confirmatory factor analysis and Rasch analysis. Int J Ment Health Addict. 2020; 1–12. Available from: 10.1007/s11469-020-00289-x
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67(6): 361–370. 10.1111/j.1600-0447.1983.tb09716.x
    1. Terkawi AS, Tsang S, AlKahtani GJ, AlKahtani GJ, Al-Mousa SH, Al Musaed S et al.. Development and validation of Arabic version of the Hospital Anxiety and Depression Scale. Saudi J Anaesth. 2017; 11(Suppl 1): S11–S18. 10.4103/sja.SJA_43_17
    1. Rodríguez-Hidalgo AJ, Pantaleón Y, Dios I, Falla D. Fear of COVID-19, stress, and anxiety in university undergraduate students: a predictive model for depression. Front Psychol. 2020; 11: 591797. 10.3389/fpsyg.2020.591797
    1. Alyami M, Albuquerque JV, Krägeloh CU, Alyami H, Henning MA. Effects of fear of COVID-19 on mental well-being and quality of life among Saudi adults: a path analysis. Saudi J Med Med Sci. 2021; 9(1): 24–30. 10.4103/sjmms.sjmms_630_20
    1. Karacin C, Bilgetekin I, Basal FB, Oksuzoglu OB. How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer. Future Oncol. 2020; 16(29): 2283–2293. 10.2217/fon-2020-0592
    1. Mertens G, Gerritsen L, Duijndam S, Salemink E, Engelhard IM. Fear of the coronavirus (COVID-19): predictors in an online study conducted in March 2020. J Anxiety Disord. 2020; 74 (2020):102258. 10.1016/j.janxdis.2020.102258.
    1. Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and positivity: mediating role of intolerance of uncertainty, depression, anxiety, and stress. Int J Ment Health Addict. 2020. Available from: 10.1007/s11469-020-00331-y.
    1. Moghanibashi A. Assessing the anxiety level of Iranian general population during COVID-19 outbreak. Asian J Psychiatr. 2020; 51: 102076. 10.1016/j.ajp.2020.102076
    1. Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018; 8(1): 2861. 10.1038/s41598-018-21243-x
    1. Vlassoff C. Gender differences in determinants and consequences of health and illness. J Health Popul Nutr. 2007; 25(1): 47–61.
    1. Lam J, Perales F. Chronic illness and mental strain: the moderating role of marital status over the disease cycle. Longit Life Course Stud. 2018; 9(3): 279–298. 10.14301/llcs.v9i3.483.
    1. Joensen LE, Madsen KP, Holm L, Nielsen KA, Rod MH, Petersen AA et al.. Research: educational and psychological aspects diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark—what characterizes people with high levels of COVID-19-related worries? Diabet Med. 2020; 37(7): 1146–1154. 10.1111/dme.14319
    1. Xiang Y, Yang Y, Li W, Zhang L, Zhang Q, Cheung T et al.. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020; 7(3): 228–229. 10.1016/S2215-0366(20)30046-8
    1. Yao H. The more exposure to media information about COVID-19, the more distressed you will feel. Brain Behav Immun. 2020; 87: 167–169. 10.1016/j.bbi.2020.05.031
    1. Smith G. Does gender influence online survey participation? A record-linkage analysis of university faculty online survey response behavior. ERIC Document Reproduction Service No. ED 501717: San José State University; 2008. Available from: .
    1. Folkman S, Greer S. Promoting psychological well-being in the face of serious illness: when theory, research and practice inform each other. Psychooncology. 2000; 9: 11–19. 10.1002/(sici)1099-1611(200001/02)9:1<11::aid-pon424>;2-z

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera